Stock Events

Stock Events

Vanda Pharmaceuticals (VNDA) Q2 2025 Earnings

7MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.57

-0.41

-0.24

-0.08

Details

Expected EPS

-0.573333

Actual EPS

-0.5

Surprise EPS

0.07

Surprise Percent

+12.79%

Description

Vanda Pharmaceuticals (VNDA) has reported earnings of -0.5 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.